Annual report
4208.TEDINET S100YD42
Period2025-04-01 → 2026-03-31
Filed2026-06-18
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 156
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥462.3bn | 2025-04-01 → 2026-03-31 | Cons. | Net sales |
| Revenue | ¥486.8bn | 2024-04-01 → 2025-03-31 | Cons. | Net sales |
| Revenue | ¥468.2bn | 2023-04-01 → 2024-03-31v | Cons. | Net sales (5-year summary) |
| Revenue | ¥494.7bn | 2022-04-01 → 2023-03-31v | Cons. | Net sales (5-year summary) |
| Revenue | ¥655.3bn | 2021-04-01 → 2022-03-31v | Cons. | Net sales (5-year summary) |
| Operating income | ¥18.9bn | 2025-04-01 → 2026-03-31 | Cons. | Operating income |
| Operating income | ¥18.0bn | 2024-04-01 → 2025-03-31 | Cons. | Operating income |
| Ordinary income | ¥37.5bn | 2025-04-01 → 2026-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥22.4bn | 2024-04-01 → 2025-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥36.3bn | 2023-04-01 → 2024-03-31v | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | −¥8.7bn | 2022-04-01 → 2023-03-31v | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥41.5bn | 2021-04-01 → 2022-03-31v | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥30.7bn | 2025-04-01 → 2026-03-31 | Cons. | Income before income taxes |
| Profit before tax | −¥10.9bn | 2024-04-01 → 2025-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥23.9bn | 2025-04-01 → 2026-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥4.8bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥29.0bn | 2023-04-01 → 2024-03-31v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥7.0bn | 2022-04-01 → 2023-03-31v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥24.5bn | 2021-04-01 → 2022-03-31v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥24.1bn | 2025-04-01 → 2026-03-31 | Cons. | Profit loss |
| Net income | −¥9.2bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss |
| Total assets | ¥946.3bn | at 2026-03-31 | Cons. | Assets |
| Total assets | ¥866.2bn | at 2025-03-31 | Cons. | Assets |
| Total assets | ¥789.0bn | at 2024-03-31v | Cons. | Total assets (5-year summary) |
| Total assets | ¥732.7bn | at 2023-03-31v | Cons. | Total assets (5-year summary) |
| Total assets | ¥838.0bn | at 2022-03-31v | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥491.4bn | at 2026-03-31 | Cons. | Liabilities |
| Total liabilities | ¥453.9bn | at 2025-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥454.9bn | at 2026-03-31 | Cons. | Net assets |
| Net assets / equity | ¥412.3bn | at 2025-03-31 | Cons. | Net assets |
| Net assets / equity | ¥429.4bn | at 2024-03-31v | Cons. | Net assets |
| Net assets / equity | ¥381.6bn | at 2023-03-31v | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥394.0bn | at 2022-03-31v | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥55.8bn | at 2026-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥116.0bn | at 2025-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥52.6bn | at 2026-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥115.4bn | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥35.9bn | at 2024-03-31v | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥30.7bn | at 2023-03-31v | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥78.8bn | at 2022-03-31v | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥60.0bn | 2025-04-01 → 2026-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥35.8bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥53.0bn | 2023-04-01 → 2024-03-31v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥18.1bn | 2022-04-01 → 2023-03-31v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥32.7bn | 2021-04-01 → 2022-03-31v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥140.2bn | 2025-04-01 → 2026-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥63.2bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥33.3bn | 2023-04-01 → 2024-03-31v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥26.0bn | 2022-04-01 → 2023-03-31v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥43.4bn | 2021-04-01 → 2022-03-31v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | ¥13.0bn | 2025-04-01 → 2026-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥105.9bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥15.7bn | 2023-04-01 → 2024-03-31v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥2.4bn | 2022-04-01 → 2023-03-31v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥8.4bn | 2021-04-01 → 2022-03-31v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥245.76 | 2025-04-01 → 2026-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-49.6 | 2024-04-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥298.59 | 2023-04-01 → 2024-03-31v | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-72.54 | 2022-04-01 → 2023-03-31v | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥249.31 | 2021-04-01 → 2022-03-31v | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥245.73 | 2025-04-01 → 2026-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥298.45 | 2023-04-01 → 2024-03-31v | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥248.56 | 2021-04-01 → 2022-03-31v | Cons. | Diluted earnings per share (5-year summary) |
| Net assets per share | ¥4,500.48 | at 2026-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥4,067.9 | at 2025-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥4,210.11 | at 2024-03-31v | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥3,726.39 | at 2023-03-31v | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥3,813.16 | at 2022-03-31v | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 46.2% | at 2026-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 45.6% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 51.8% | at 2024-03-31v | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 49.4% | at 2023-03-31v | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 44.1% | at 2022-03-31v | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 5.7% | 2025-04-01 → 2026-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | -1.2% | 2024-04-01 → 2025-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 7.5% | 2023-04-01 → 2024-03-31v | Cons. | Rate of return on equity (5-year summary) |
| ROE | -1.9% | 2022-04-01 → 2023-03-31v | Cons. | Rate of return on equity (5-year summary) |
| ROE | 6.7% | 2021-04-01 → 2022-03-31v | Cons. | Rate of return on equity (5-year summary) |
| Employees | 7,968 | at 2026-03-31 | Cons. | Number of employees |
| Employees | 7,563 | at 2025-03-31 | Cons. | Number of employees |
| Employees | 7,882 | at 2024-03-31v | Cons. | Number of employees |
| Employees | 8,028 | at 2023-03-31v | Cons. | Number of employees |
| Employees | 9,849 | at 2022-03-31v | Cons. | Number of employees |
| Revenue | ¥154.8bn | 2025-04-01 → 2026-03-31 | Standalone | Net sales |
| Revenue | ¥162.1bn | 2024-04-01 → 2025-03-31 | Standalone | Net sales |
| Revenue | ¥164.0bn | 2023-04-01 → 2024-03-31v | Standalone | Net sales (5-year summary) |
| Revenue | ¥182.4bn | 2022-04-01 → 2023-03-31v | Standalone | Net sales (5-year summary) |
| Revenue | ¥274.8bn | 2021-04-01 → 2022-03-31v | Standalone | Net sales (5-year summary) |
| Operating income | ¥3.1bn | 2025-04-01 → 2026-03-31 | Standalone | Operating income |
| Operating income | ¥1.0bn | 2024-04-01 → 2025-03-31 | Standalone | Operating income |
| Ordinary income | ¥25.2bn | 2025-04-01 → 2026-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥22.4bn | 2024-04-01 → 2025-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥20.5bn | 2023-04-01 → 2024-03-31v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥23.7bn | 2022-04-01 → 2023-03-31v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥28.1bn | 2021-04-01 → 2022-03-31v | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥24.1bn | 2025-04-01 → 2026-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥5.7bn | 2024-04-01 → 2025-03-31 | Standalone | Income before income taxes |
| Net income | ¥22.2bn | 2025-04-01 → 2026-03-31 | Standalone | Profit loss |
| Net income | ¥9.7bn | 2024-04-01 → 2025-03-31 | Standalone | Profit loss |
| Net income | ¥16.5bn | 2023-04-01 → 2024-03-31v | Standalone | Net income loss (5-year summary) |
| Net income | ¥19.1bn | 2022-04-01 → 2023-03-31v | Standalone | Net income loss (5-year summary) |
| Net income | ¥21.4bn | 2021-04-01 → 2022-03-31v | Standalone | Net income loss (5-year summary) |
| Total assets | ¥607.3bn | at 2026-03-31 | Standalone | Assets |
| Total assets | ¥637.1bn | at 2025-03-31 | Standalone | Assets |
| Total assets | ¥463.6bn | at 2024-03-31v | Standalone | Total assets (5-year summary) |
| Total assets | ¥450.6bn | at 2023-03-31v | Standalone | Total assets (5-year summary) |
| Total assets | ¥485.4bn | at 2022-03-31v | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥391.0bn | at 2026-03-31 | Standalone | Liabilities |
| Total liabilities | ¥434.1bn | at 2025-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥216.3bn | at 2026-03-31 | Standalone | Net assets |
| Net assets / equity | ¥202.9bn | at 2025-03-31 | Standalone | Net assets |
| Net assets / equity | ¥203.2bn | at 2024-03-31v | Standalone | Net assets |
| Net assets / equity | ¥193.8bn | at 2023-03-31v | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥184.1bn | at 2022-03-31v | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥9.2bn | at 2026-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥61.0bn | at 2025-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥228.56 | 2025-04-01 → 2026-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥100.4 | 2024-04-01 → 2025-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥170.08 | 2023-04-01 → 2024-03-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥197.04 | 2022-04-01 → 2023-03-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥217.38 | 2021-04-01 → 2022-03-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥228.53 | 2025-04-01 → 2026-03-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥100.36 | 2024-04-01 → 2025-03-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥170 | 2023-04-01 → 2024-03-31v | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥196.82 | 2022-04-01 → 2023-03-31v | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥216.72 | 2021-04-01 → 2022-03-31v | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥110 | 2025-04-01 → 2026-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥110 | 2024-04-01 → 2025-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥105 | 2023-04-01 → 2024-03-31v | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥95 | 2022-04-01 → 2023-03-31v | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥95 | 2021-04-01 → 2022-03-31v | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥2,226.28 | at 2026-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,089.11 | at 2025-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,092.43 | at 2024-03-31v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,996.63 | at 2023-03-31v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,896.64 | at 2022-03-31v | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 35.6% | at 2026-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 31.8% | at 2025-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 43.8% | at 2024-03-31v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 43.0% | at 2023-03-31v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 37.8% | at 2022-03-31v | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 10.6% | 2025-04-01 → 2026-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 4.8% | 2024-04-01 → 2025-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 8.3% | 2023-04-01 → 2024-03-31v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 10.1% | 2022-04-01 → 2023-03-31v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 11.6% | 2021-04-01 → 2022-03-31v | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 106,200,000 | at 2026-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 106,200,000 | at 2025-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 106,200,000 | at 2024-03-31v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 106,200,000 | at 2023-03-31v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 106,200,000 | at 2022-03-31v | Standalone | Total number of issued shares (5-year summary) |
| Employees | 2,778 | at 2026-03-31 | Standalone | Number of employees |
| Employees | 2,693 | at 2025-03-31 | Standalone | Number of employees |
| Employees | 2,243 | at 2024-03-31v | Standalone | Number of employees |
| Employees | 2,216 | at 2023-03-31v | Standalone | Number of employees |
| Employees | 2,058 | at 2022-03-31v | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 120
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | employees | at 2026-03-31 | 1112 pure |
| Otherother segments | capex | 2025-04-01 → 2026-03-31 | ¥1.2bn |
| Otherother segments | depreciation | 2025-04-01 → 2026-03-31 | ¥1.7bn |
| Otherother segments | revenue | 2025-04-01 → 2026-03-31 | ¥34.5bn |
| Otherother segments | revenue external | 2025-04-01 → 2026-03-31 | ¥48.1bn |
| Otherother segments | revenue intersegment | 2025-04-01 → 2026-03-31 | −¥13.7bn |
| Otherother segments | segment assets | at 2026-03-31 | ¥52.4bn |
| Otherother segments | segment profit | 2025-04-01 → 2026-03-31 | ¥1.9bn |
| Reconciling Itemsreconciling | capex | 2025-04-01 → 2026-03-31 | ¥4.4bn |
| Reconciling Itemsreconciling | depreciation | 2025-04-01 → 2026-03-31 | ¥3.2bn |
| Reconciling Itemsreconciling | revenue | 2025-04-01 → 2026-03-31 | −¥21.2bn |
| Reconciling Itemsreconciling | revenue intersegment | 2025-04-01 → 2026-03-31 | −¥21.2bn |
| Reconciling Itemsreconciling | segment assets | at 2026-03-31 | ¥235.6bn |
| Reconciling Itemsreconciling | segment profit | 2025-04-01 → 2026-03-31 | −¥5.4bn |
| High Performance Urethansreportable segment | capex | 2025-04-01 → 2026-03-31 | ¥4.1bn |
| High Performance Urethansreportable segment | depreciation | 2025-04-01 → 2026-03-31 | ¥3.4bn |
| High Performance Urethansreportable segment | employees | at 2026-03-31 | 496 pure |
| High Performance Urethansreportable segment | revenue | 2025-04-01 → 2026-03-31 | ¥46.5bn |
| High Performance Urethansreportable segment | revenue external | 2025-04-01 → 2026-03-31 | ¥46.1bn |
| High Performance Urethansreportable segment | revenue intersegment | 2025-04-01 → 2026-03-31 | ¥419m |
| High Performance Urethansreportable segment | segment assets | at 2026-03-31 | ¥129.1bn |
| High Performance Urethansreportable segment | segment profit | 2025-04-01 → 2026-03-31 | −¥548m |
| Machineryreportable segment | capex | 2025-04-01 → 2026-03-31 | ¥3.3bn |
| Machineryreportable segment | depreciation | 2025-04-01 → 2026-03-31 | ¥1.7bn |
| Machineryreportable segment | employees | at 2026-03-31 | 1572 pure |
| Machineryreportable segment | revenue | 2025-04-01 → 2026-03-31 | ¥68.4bn |
| Machineryreportable segment | revenue external | 2025-04-01 → 2026-03-31 | ¥68.1bn |
| Machineryreportable segment | revenue intersegment | 2025-04-01 → 2026-03-31 | ¥327m |
| Machineryreportable segment | segment assets | at 2026-03-31 | ¥78.1bn |
| Machineryreportable segment | segment profit | 2025-04-01 → 2026-03-31 | ¥6.2bn |
| Pharmaceuticalreportable segment | capex | 2025-04-01 → 2026-03-31 | ¥3.9bn |
| Pharmaceuticalreportable segment | depreciation | 2025-04-01 → 2026-03-31 | ¥2.5bn |
| Pharmaceuticalreportable segment | employees | at 2026-03-31 | 521 pure |
| Pharmaceuticalreportable segment | revenue | 2025-04-01 → 2026-03-31 | ¥21.0bn |
| Pharmaceuticalreportable segment | revenue external | 2025-04-01 → 2026-03-31 | ¥20.6bn |
| Pharmaceuticalreportable segment | revenue intersegment | 2025-04-01 → 2026-03-31 | ¥364m |
| Pharmaceuticalreportable segment | segment assets | at 2026-03-31 | ¥41.1bn |
| Pharmaceuticalreportable segment | segment profit | 2025-04-01 → 2026-03-31 | −¥1.3bn |
| Polymers And Chemicalsreportable segment | capex | 2025-04-01 → 2026-03-31 | ¥40.4bn |
| Polymers And Chemicalsreportable segment | depreciation | 2025-04-01 → 2026-03-31 | ¥8.6bn |
| Polymers And Chemicalsreportable segment | employees | at 2026-03-31 | 1662 pure |
| Polymers And Chemicalsreportable segment | revenue | 2025-04-01 → 2026-03-31 | ¥251.2bn |
| Polymers And Chemicalsreportable segment | revenue external | 2025-04-01 → 2026-03-31 | ¥228.4bn |
| Polymers And Chemicalsreportable segment | revenue intersegment | 2025-04-01 → 2026-03-31 | ¥22.8bn |
| Polymers And Chemicalsreportable segment | segment assets | at 2026-03-31 | ¥307.2bn |
| Polymers And Chemicalsreportable segment | segment profit | 2025-04-01 → 2026-03-31 | ¥8.2bn |
| Specialty Productsreportable segment | capex | 2025-04-01 → 2026-03-31 | ¥11.6bn |
| Specialty Productsreportable segment | depreciation | 2025-04-01 → 2026-03-31 | ¥4.6bn |
| Specialty Productsreportable segment | employees | at 2026-03-31 | 610 pure |
| Specialty Productsreportable segment | revenue | 2025-04-01 → 2026-03-31 | ¥61.9bn |
| Specialty Productsreportable segment | revenue external | 2025-04-01 → 2026-03-31 | ¥50.9bn |
| Specialty Productsreportable segment | revenue intersegment | 2025-04-01 → 2026-03-31 | ¥11.0bn |
| Specialty Productsreportable segment | segment assets | at 2026-03-31 | ¥102.8bn |
| Specialty Productsreportable segment | segment profit | 2025-04-01 → 2026-03-31 | ¥9.8bn |
| —segment total | capex | 2025-04-01 → 2026-03-31 | ¥64.6bn |
| —segment total | depreciation | 2025-04-01 → 2026-03-31 | ¥22.5bn |
| —segment total | revenue | 2025-04-01 → 2026-03-31 | ¥483.6bn |
| —segment total | revenue external | 2025-04-01 → 2026-03-31 | ¥462.3bn |
| —segment total | revenue intersegment | 2025-04-01 → 2026-03-31 | ¥21.2bn |
| —segment total | segment assets | at 2026-03-31 | ¥710.7bn |
| —segment total | segment profit | 2025-04-01 → 2026-03-31 | ¥24.3bn |
| Otherother segments | capex | 2024-04-01 → 2025-03-31 | ¥1.2bn |
| Otherother segments | depreciation | 2024-04-01 → 2025-03-31 | ¥1.9bn |
| Otherother segments | revenue | 2024-04-01 → 2025-03-31 | ¥39.2bn |
| Otherother segments | revenue external | 2024-04-01 → 2025-03-31 | ¥50.1bn |
| Otherother segments | revenue intersegment | 2024-04-01 → 2025-03-31 | −¥10.9bn |
| Otherother segments | segment assets | at 2025-03-31 | ¥52.8bn |
| Otherother segments | segment profit | 2024-04-01 → 2025-03-31 | ¥2.1bn |
| Reconciling Itemsreconciling | capex | 2024-04-01 → 2025-03-31 | ¥5.4bn |
| Reconciling Itemsreconciling | depreciation | 2024-04-01 → 2025-03-31 | ¥2.8bn |
| Reconciling Itemsreconciling | revenue | 2024-04-01 → 2025-03-31 | −¥26.1bn |
| Reconciling Itemsreconciling | revenue intersegment | 2024-04-01 → 2025-03-31 | −¥26.1bn |
| Reconciling Itemsreconciling | segment assets | at 2025-03-31 | ¥235.9bn |
| Reconciling Itemsreconciling | segment profit | 2024-04-01 → 2025-03-31 | −¥3.8bn |
| High Performance Urethansreportable segment | capex | 2024-04-01 → 2025-03-31 | ¥582m |
| High Performance Urethansreportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥838m |
| High Performance Urethansreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥15.6bn |
| High Performance Urethansreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥15.1bn |
| High Performance Urethansreportable segment | revenue intersegment | 2024-04-01 → 2025-03-31 | ¥549m |
| High Performance Urethansreportable segment | segment assets | at 2025-03-31 | ¥98.7bn |
| High Performance Urethansreportable segment | segment profit | 2024-04-01 → 2025-03-31 | −¥200m |
| Machineryreportable segment | capex | 2024-04-01 → 2025-03-31 | ¥2.9bn |
| Machineryreportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥2.0bn |
| Machineryreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥86.9bn |
| Machineryreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥86.4bn |
| Machineryreportable segment | revenue intersegment | 2024-04-01 → 2025-03-31 | ¥514m |
| Machineryreportable segment | segment assets | at 2025-03-31 | ¥79.0bn |
| Machineryreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥7.9bn |
| Pharmaceuticalreportable segment | capex | 2024-04-01 → 2025-03-31 | ¥2.8bn |
| Pharmaceuticalreportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥2.0bn |
| Pharmaceuticalreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥31.5bn |
| Pharmaceuticalreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥29.8bn |
| Pharmaceuticalreportable segment | revenue intersegment | 2024-04-01 → 2025-03-31 | ¥1.7bn |
| Pharmaceuticalreportable segment | segment assets | at 2025-03-31 | ¥39.9bn |
| Pharmaceuticalreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥1.2bn |
| Polymers And Chemicalsreportable segment | capex | 2024-04-01 → 2025-03-31 | ¥33.5bn |
| Polymers And Chemicalsreportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥13.5bn |
| Polymers And Chemicalsreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥273.6bn |
| Polymers And Chemicalsreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥255.2bn |
| Polymers And Chemicalsreportable segment | revenue intersegment | 2024-04-01 → 2025-03-31 | ¥18.3bn |
| Polymers And Chemicalsreportable segment | segment assets | at 2025-03-31 | ¥265.9bn |
| Polymers And Chemicalsreportable segment | segment profit | 2024-04-01 → 2025-03-31 | −¥713m |
| Specialty Productsreportable segment | capex | 2024-04-01 → 2025-03-31 | ¥14.2bn |
| Specialty Productsreportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥4.1bn |
| Specialty Productsreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥66.2bn |
| Specialty Productsreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥50.3bn |
| Specialty Productsreportable segment | revenue intersegment | 2024-04-01 → 2025-03-31 | ¥15.9bn |
| Specialty Productsreportable segment | segment assets | at 2025-03-31 | ¥94.0bn |
| Specialty Productsreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥11.7bn |
| —segment total | capex | 2024-04-01 → 2025-03-31 | ¥55.3bn |
| —segment total | depreciation | 2024-04-01 → 2025-03-31 | ¥24.4bn |
| —segment total | revenue | 2024-04-01 → 2025-03-31 | ¥512.9bn |
| —segment total | revenue external | 2024-04-01 → 2025-03-31 | ¥486.8bn |
| —segment total | revenue intersegment | 2024-04-01 → 2025-03-31 | ¥26.1bn |
| —segment total | segment assets | at 2025-03-31 | ¥630.3bn |
| —segment total | segment profit | 2024-04-01 → 2025-03-31 | ¥21.8bn |
| High Performance Urethansreportable segment | employees | at 2026-03-31 | 19 pure |
| Pharmaceuticalreportable segment | employees | at 2026-03-31 | 517 pure |
| Polymers And Chemicalsreportable segment | employees | at 2026-03-31 | 80 pure |
| Specialty Productsreportable segment | employees | at 2026-03-31 | 167 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 2,032
| Item | Context | Value | Unit |
|---|---|---|---|
| Asset retirement obligations ncl | CurrentYearInstant | 1763000000 | JPY |
| Other ncl | Prior1YearInstant | 6603000000 | JPY |
| Other ncl | CurrentYearInstant | 6767000000 | JPY |
| Noncurrent liabilities | Prior1YearInstant | 256169000000 | JPY |
| Noncurrent liabilities | CurrentYearInstant | 287471000000 | JPY |
| Liabilities | Prior1YearInstant | 453888000000 | JPY |
| Liabilities | CurrentYearInstant | 491379000000 | JPY |
| Capital stock | Prior1YearInstant | 58435000000 | JPY |
| Capital stock | CurrentYearInstant | 58435000000 | JPY |
| Capital surplus | Prior1YearInstant | 40363000000 | JPY |
| Capital surplus | CurrentYearInstant | 40355000000 | JPY |
| Retained earnings | Prior1YearInstant | 260914000000 | JPY |
| Retained earnings | CurrentYearInstant | 274102000000 | JPY |
| Treasury stock | Prior1YearInstant | -21486000000 | JPY |
| Treasury stock | CurrentYearInstant | -21429000000 | JPY |
| Shareholders equity | Prior1YearInstant | 338226000000 | JPY |
| Shareholders equity | CurrentYearInstant | 351463000000 | JPY |
| Valuation difference on available for sale securities | Prior1YearInstant | 7555000000 | JPY |
| Valuation difference on available for sale securities | CurrentYearInstant | 11543000000 | JPY |
| Deferred gains or losses on hedges | Prior1YearInstant | 12000000 | JPY |
| Deferred gains or losses on hedges | CurrentYearInstant | -2000000 | JPY |
| Foreign currency translation adjustment | Prior1YearInstant | 41331000000 | JPY |
| Foreign currency translation adjustment | CurrentYearInstant | 62652000000 | JPY |
| Remeasurements of defined benefit plans | Prior1YearInstant | 7954000000 | JPY |
| Remeasurements of defined benefit plans | CurrentYearInstant | 11544000000 | JPY |
| Valuation and translation adjustments | Prior1YearInstant | 56852000000 | JPY |
| Valuation and translation adjustments | CurrentYearInstant | 85737000000 | JPY |
| Subscription rights to shares | Prior1YearInstant | 24000000 | JPY |
| Subscription rights to shares | CurrentYearInstant | 13000000 | JPY |
| Non controlling interests | Prior1YearInstant | 17190000000 | JPY |
| Non controlling interests | CurrentYearInstant | 17721000000 | JPY |
| Net assets | Prior1YearInstant | 412292000000 | JPY |
| Net assets | CurrentYearInstant | 454934000000 | JPY |
| Liabilities and net assets | Prior1YearInstant | 866180000000 | JPY |
| Liabilities and net assets | CurrentYearInstant | 946313000000 | JPY |
| Net sales | Prior1YearDuration | 486802000000 | JPY |
| Net sales | CurrentYearDuration | 462343000000 | JPY |
| Cost of sales | Prior1YearDuration | 395869000000 | JPY |
| Cost of sales | CurrentYearDuration | 358886000000 | JPY |
| Gross profit | Prior1YearDuration | 90933000000 | JPY |
| Gross profit | CurrentYearDuration | 103457000000 | JPY |
| Selling general and administrative expenses | Prior1YearDuration | 72891000000 | JPY |
| Selling general and administrative expenses | CurrentYearDuration | 84516000000 | JPY |
| Operating income | Prior1YearDuration | 18042000000 | JPY |
| Operating income | CurrentYearDuration | 18941000000 | JPY |
| Interest income noi | Prior1YearDuration | 749000000 | JPY |
| Interest income noi | CurrentYearDuration | 555000000 | JPY |
| Dividends income noi | Prior1YearDuration | 528000000 | JPY |
| Dividends income noi | CurrentYearDuration | 447000000 | JPY |
| Rent income noi | Prior1YearDuration | 895000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |